Overall rank by patents
#1,132
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
10x Genomics, Inc.
USPTO PatentsView assignee record — 373 granted patents across 35 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
373
Total patents granted
35
CPC technology areas
26.5
Avg claims per patent
+478%
5-year filing velocity
Portfolio overview
10x Genomics, Inc. has been granted 373 US utility patents between 2016 and 2025, placing 10x Genomics, Inc. at rank #1,132 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 26.5 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, 10x Genomics, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 68.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 318 grants, compared with 55 in the 2015–2019 window — a +478% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 10x Genomics, Inc.'s 26.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 10x Genomics, Inc. against peers pursuing similar technology classes.
How does 10x compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- 10x Genomics ◀ 373
10x Genomics, Inc.
373 patents
What this shows 10x holds 373 patents — placing it at rank #1,132 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2016–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 1.1% |
| 2017 | 7 | 1.9% |
| 2018 | 15 | 4.0% |
| 2019 | 29 | 7.8% |
| 2020 | 41 | 11.0% |
| 2021 | 22 | 5.9% |
| 2022 | 29 | 7.8% |
| 2023 | 62 | 16.6% |
| 2024 | 82 | 22.0% |
| 2025 | 82 | 22.0% |
Which technologies does 10x Genomics, Inc. patent most?
Top 15 of 35 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does 10x Genomics, Inc. hold?
10x Genomics, Inc. holds 373 US granted patents filed between 2016 and 2025, spanning 35 technology areas.
What is 10x Genomics, Inc.'s Innovation Score?
10x Genomics, Inc. has an Innovation Score of 68.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does 10x Genomics, Inc. focus on?
10x Genomics, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 282 patents. The company has filed patents in 35 CPC subclasses total.
Is 10x Genomics, Inc.'s patent filing rate increasing or decreasing?
10x Genomics, Inc.'s recent filing velocity is +478% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for 10x Genomics, Inc.'s patents?
10x Genomics, Inc.'s patents average 26.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the 10x Genomics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C12Q technology
10x Genomics, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where 10x Genomics, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
